Source | hl7.fhir.uv.ichom-breast-cancer#current:ICHOM Patient Centered Outcomes Measure Set for Breast Cancer (v4.0.1) |
resourceType | Questionnaire |
id | ClinicalResponseBaseline |
canonical | http://hl7.org/fhir/uv/ichom-breast-cancer/Questionnaire/ClinicalResponseBaseline |
version | 1.0.0 |
status | draft |
publisher | HL7 International - Clinical Interoperability Council Group |
name | ClinicalResponseBaseline |
title | Clinical response questionnaire at baseline |
date | 2023-08-18T15:07:30+00:00 |
experimental | true |
description | Clinical response questionnaire at baseline (first doctors' visit) |
jurisdictions | uv |
Usages | (none) |
General information*
What is the patient's medical record number? *
What is the patient's last name? *
Demographic factors*
Indicate the sex of the patient at birth: *
In what year was the patient born? *
Clinical factors*
Indicate the laterality of breast cancer *
Indicate if this is the first breast cancer *
Indicate if this is a new cancer on contralateral or ipsilateral breast *
Tumor factors*
Is the date of histological diagnosis known? *
Indicate the initial date of histological diagnosis: *
Indicate the histologic type of the tumor (select all that apply) *
Indicate if the patient carries a germline mutation predisposing breast cancer *
Indicate the grade of the invasive component of tumor *
Indicate the tumor grade of DCIS component of tumor *
Indicate the clinical tumor stage (per AJCC 8th Ed.): *
Indicate the clinical nodal stage (per AJCC 8th Ed.): *
Indicate the clinical distant metastasis (per AJCC 8th Ed.): *
Indicate if the estrogen receptor status is positive: *
Indicate if the progesterone receptor status is positive: *
Indicate if the HER2 receptor status is positive: *
Indicate if a molecular profiling tool was used. If so, which one? *
Indicate the mammaprint score on a scale of 0.000 to 1.000 *
Indicate the oncotype score on a scale of 0 to 100 *
Indicate the endopredict score on a scale of 1.1 to 6.2 *
Treatment variables*
Indicate if a multidisciplinary meeting was conducted *
Which treatments did the multidisciplinary team recommend (select all that apply)? *
Produced 08 Sep 2023